The role of GLP-1 receptor agonists among patients with HF also remains unclear, and their effects may differ in patients with and without established HF, particularly those with decompensated heart failure with reduced ejection fraction (Nassif and Kosiborod, 2019). The gene discussed is GLP1R; the disease is heart failure.